|Keywords:||Peanut, Clinical Trial, Allergy, Peanut Allergy, Allergy Trial, monotherapy|
The safety and efficacy of dupilumab for this use has not been evaluated by any regulatory authority.
We will go over all eligibility criteria during a screening visit.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.